Substrates for peptidase S01.140: chymase (Homo sapiens-type)
Peptide and protein substrates that are thought to be physiologically relevant are indicated by P. Peptide and protein substrates that are thought to be pathologically relevant are indicated by D. Peptide and protein substrates that are not physiologically relevant are indicated by N. Synthetic substrates are indicated by S. Click on the symbol to show only physiological, non-physiological or synthetic substrates, or here to display all substrates. How cleavage sites have been identified are indicated by the following evidence codes: NT = N-terminal sequencing, MS = mass spectroscopy, MU = mutation, CS = consensus sequence, LC = liquid chromatography. To see all annotated cleavages for a protein substrate, click on the UniProt Accession.
| Substrate | Uniprot | Residue range | Cleavage Site | Cleavage type | Evidence | P4 | P3 | P2 | P1 | P1' | P2' | P3' | P4' | Reference | CutDB | MERNUM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Abz-Asn-Lys-Ile-Ser-Tyr-Gln-Ser-Ser-Ser-Gln-EDDnp | Abz-Asn-Lys-Ile-Ser-Tyr+Gln-Ser-Ser-Ser-Gln-EDDnp | S | Lys | Ile | Ser | Tyr | Gln | Ser | Ser | Ser | Réhault et al., 2002 | |||||
| Abz-Ile-Ser-Tyr-Gln-Ser-Ser-Ser-Thr-Glu-Glu-Gln-EDDnp | Abz-Ile-Ser-Tyr+Gln-Ser-Ser-Ser-Thr-Glu-Glu-Gln-EDDnp | S | Abz | Ile | Ser | Tyr | Gln | Ser | Ser | Ser | Réhault et al., 2002 | |||||
| Abz-Ser-Ser-Gln-Tyr-Ser-Asn-Thr-Glu-Glu-Gln-EDDnp | Abz-Ser-Ser-Gln-Tyr+Ser-Asn-Thr-Glu-Glu-Gln-EDDnp | S | Ser | Ser | Gln | Tyr | Ser | Asn | Thr | Glu | Réhault et al., 2002 | |||||
| Abz-Ser-Ser-Ile-Tyr-Ser-Gln-Thr-Glu-Glu-Gln-EDDnp | Abz-Ser-Ser-Ile-Tyr+Ser-Gln-Thr-Glu-Glu-Gln-EDDnp | S | Ser | Ser | Ile | Tyr | Ser | Gln | Thr | Glu | Réhault et al., 2002 | |||||
| alpha-2-macroglobulin | P01023 | 24-1474 | peptide-Phe707+Tyr-peptide | P | Arg | Val | Gly | Phe | Tyr | Glu | Ser | Asp | Walter et al., 1999 | 19534 | ||
| alpha-2-macroglobulin | P01023 | 24-1474 | peptide-Tyr708+Glu-peptide | P | Val | Gly | Phe | Tyr | Glu | Ser | Asp | Val | Walter et al., 1999 | 19535 | ||
| angiotensin 1-12 | P01019 | 34-45 | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe+His-Leu-Val-Ile | P | NT | Ile | His | Pro | Phe | His | Leu | Val | Ile | Reyes et al., 2017 | ||
| angiotensin-1 | P01019 | 34-43 | Asp-Arg-Val-Tyr-Ile-His-Pro-Phe+His-Leu | P | Ile | His | Pro | Phe | His | Leu | - | - | Caughey et al., 2000 | |||
| angiotensin-1 | P01019 | 34-43 | Asp-Arg-Val-Tyr+Ile-His-Pro-Phe-His-Leu | P | Asp | Arg | Val | Tyr | Ile | His | Pro | Phe | Raymond et al., 2003 | 3202 | ||
| apolipoprotein A-I | P02647 | 25-267 | peptide-Tyr42+Val-peptide | P | Ala | Thr | Val | Tyr | Val | Asp | Val | Leu | Andersson et al., 2008 | 20897 | ||
| apolipoprotein A-I | P02647 | 25-267 | peptide-Phe57+Glu-peptide | P | Val | Ser | Gln | Phe | Glu | Gly | Ser | Ala | Andersson et al., 2008 | 20898 | ||
| apolipoprotein A-I precursor | P02647 | 1-267 | peptide-Phe249+Lys-peptide | P | Leu | Glu | Ser | Phe | Lys | Val | Ser | Phe | Lee et al., 2003 | 20899 | ||
| big endothelin 1 | P05305 | 53-90 | peptide-Tyr83+Gly-peptide | P | Val | Val | Pro | Tyr | Gly | Leu | Gly | Ser | Raymond et al., 2003 | |||
| big endothelin 3 precursor | P14138 | 17-238 | peptide-Tyr127+Gly-peptide | P | Thr | Val | Pro | Tyr | Gly | Leu | Ser | Asn | Nakano et al., 1997 | 3201 | ||
| bradykinin | P01042 | 381-389 | Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe+Arg | P | Phe | Ser | Pro | Phe | Arg | - | - | - | Raymond et al., 2003 | 19530 | ||
| Bz-Tyr-OEt | Bz-Tyr+OEt | S | - | - | Bz | Tyr | OEt | - | - | - | Caughey, 2004 | |||||
| Chymase | A7WPL7 | 117-143 | Peptide-Leu122+Thr-Peptide | P | NT | Lys | Ala | Asn | Leu | Thr | Leu | Ala | Val | Caughey et al., 2008 | ||
| Chymase | A7WPL7 | 117-143 | Peptide-Leu124+Ala-Peptide | P | NT | Asn | Leu | Thr | Leu | Ala | Val | Gly | Thr | Caughey et al., 2008 | ||
| Chymase | A7WPL7 | 117-143 | Peptide-Gly127+Thr-Peptide | P | NT | Leu | Ala | Val | Gly | Thr | Leu | Pro | Leu | Caughey et al., 2008 | ||
| Chymase | A7WPL7 | 117-143 | Peptide-Leu129+Pro-Peptide | P | NT | Val | Gly | Thr | Leu | Pro | Leu | Pro | Pro | Caughey et al., 2008 | ||
| Chymase | A7WPL7 | 117-143 | Peptide-Leu138+Thr-Peptide | P | NT | Cys | Asn | Phe | Leu | Thr | Ser | Gly | Arg | Caughey et al., 2008 | ||
| chymase precursor | P23946 | 22-247 | peptide-Phe135+Asn-peptide | P | Pro | Ser | Gln | Phe | Asn | Phe | Val | Pro | Raymond et al., 2003 | 19526 | ||
| coagulation factor C | P28175 | 26-1019 | peptide-Phe+Ile-peptide | P | Arg | Ser | Pro | Phe | Ile | Trp | Asn | Gly | Kawabata et al., 2004 | |||
| collagen alpha-1(I) chain | P02452 | 23-1464 | peptide-Leu1238+Ser-peptide | P | Leu | Lys | Ser | Leu | Ser | Gln | Gln | Ile | Kofford et al., 1997 | 19533 | ||
| Connective tissue-activating peptide III | P02775 | 44-128 | peptide-Tyr58+Ala-peptide | P | AB | Ser | Asp | Leu | Tyr | Ala | Glu | Leu | Arg | Schiemann et al., 2006 | ||
| endothelin-1 precursor | P22388 | 26-202 | peptide-Tyr83+Gly-peptide | N | Val | Val | Pro | Tyr | Gly | Leu | Gly | Ser | Nakano et al., 1997 | 3199 | ||
| endothelin-2 precursor | P20800 | 25-178 | peptide-Tyr79+Gly-peptide | P | Thr | Ala | Pro | Tyr | Gly | Leu | Gly | Asn | Nakano et al., 1997 | |||
| fibronectin | P02751 | 32-2386 | peptide-Phe286+Thr-peptide | P | Ser | Gly | Pro | Phe | Thr | Asp | Val | Arg | Andersson et al., 2008 | |||
| fibronectin | P02751 | 32-2386 | peptide-Phe2052+Glu-peptide | P | Gln | Met | Ile | Phe | Glu | Glu | His | Gly | Andersson et al., 2008 | |||
| Fibulin-2 | P37889-1 | 27-1221 | peptide-Phe405+Arg-peptide | P | NT | Leu | Pro | Arg | Phe | Arg | Ala | Glu | Glu | Sasaki et al., 1996 | ||
| Fibulin-2 | P37889-1 | 27-1221 | peptide-Tyr783+Lys-peptide | P | NT | Phe | Gln | Cys | Tyr | Lys | Ala | Leu | Thr | Sasaki et al., 1996 | ||
| hepatocyte growth factor | P14210 | 32-728 | peptide-Leu480+Asp-peptide | P | Ile | Val | Asn | Leu | Asp | His | Pro | Val | Andersson et al., 2008 | |||
| Hepatocyte growth factor | P14210 | 32-728 | peptide-Leu493+Arg-peptide | P | MS | Thr | Lys | Gln | Leu | Arg | Val | Val | Asn | Raymond et al., 2006 | ||
| interleukin-1 beta precursor | P01584 | 1-269 | peptide-Tyr113+Val-peptide | P | Asn | Glu | Ala | Tyr | Val | His | Asp | Ala | Raymond et al., 2003 | 19528 | ||
| interleukin-18 | Q14116 | 37-193 | peptide-Phe57+Ile-peptide | P | Gln | Val | Leu | Phe | Ile | Asp | Gln | Gly | Andersson et al., 2008 | |||
| interleukin-18 | Q14116 | 37-193 | peptide-Phe151+Glu-peptide | P | Lys | Met | Gln | Phe | Glu | Ser | Ser | Ser | Andersson et al., 2008 | |||
| kit ligand | P21583 | 26-273 | peptide-Phe183+Met-peptide | P | Thr | Lys | Pro | Phe | Met | Leu | Pro | Pro | Raymond et al., 2003 | 3203 | ||
| leukocyte elastase inhibitor | P30740 | 1-379 | peptide-Phe343+Cys-peptide | P | Ile | Ala | Thr | Phe | Cys | Met | Leu | Met | Cooley et al., 2001 | 20487 | ||
| matrix metallopeptidase-1 precursor | P03956 | 20-469 | peptide-Leu102+Thr-peptide | P | Gln | Phe | Val | Leu | Thr | Glu | Gly | Asn | Raymond et al., 2003 | 3204 | ||
| matrix metallopeptidase-9 precursor | O18733 | 20-704 | peptide-Phe110+Glu-peptide | P | Phe | Gln | Thr | Phe | Glu | Gly | Asp | Leu | Fang et al., 1997 | 19761 | ||
| matrix metallopeptidase-9 precursor | O18733 | 20-704 | peptide-Phe107+Gln-peptide | P | Leu | Gly | Lys | Phe | Gln | Thr | Phe | Glu | Fang et al., 1997 | 19760 | ||
| Metalloproteinase inhibitor 1 | P01033 | 24-207 | Peptide-Phe35+Cys-Peptide | P | NT | Gln | Thr | Ala | Phe | Cys | Asn | Ser | Asp | Frank et al., 2001 | ||
| Metalloproteinase inhibitor 1 | P01033 | 24-207 | Peptide-Phe46+Val-Peptide | P | NT | Arg | Ala | Lys | Phe | Val | Gly | Thr | Pro | Frank et al., 2001 | ||
| Metalloproteinase inhibitor 1 | P01033 | 24-207 | Peptide-Phe124+Val-Peptide | P | NT | Thr | Cys | Ser | Phe | Val | Ala | Pro | Trp | Frank et al., 2001 | ||
| Metalloproteinase inhibitor 1 | P01033 | 24-207 | Peptide-Trp128+Asn-Peptide | P | NT | Val | Ala | Pro | Trp | Asn | Ser | Leu | Ser | Frank et al., 2001 | ||
| neurotensin | P30990 | 151-163 | Glp-Leu-Tyr-Glu-Asn-Lys-Pro-Arg-Arg-Pro-Tyr+Ile-Leu | P | Arg | Arg | Pro | Tyr | Ile | Leu | - | - | Raymond et al., 2003 | 19529 | ||
| nidogen-1 | P10493 | 29-1245 | peptide-Phe378+Ser-peptide | P | Gly | Val | Val | Phe | Ser | Tyr | Asn | Thr | Walker et al., 1998 | |||
| phenylalanyl bond | peptide-Phe+peptide | N | - | - | NPe | Phe | CPe | - | - | - | Caughey, 2004 | |||||
| Plasma protease C1 inhibitor | P05155 | 23-500 | peptide-Phe55+Val-peptide | P | Lys | Met | Leu | Phe | Val | Glu | Pro | Ile | Raymond et al., 2003 | 19525 | ||
| Pro-Gly-Gly-Ala-Ala-Val-Ile-Ala-Met-Phe-Ala-Gly-(His)6 | Pro-Gly-Gly-Ala-Ala-Val-Ile-Ala-Met-Phe+Ala-Gly-(His)6 | N | NU | Ile | Ala | Met | Phe | Ala | Gly | His | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Ala-Arg-Arg-Val-Thr-Phe-Asp-Ser-Leu-(His)6 | Pro-Gly-Gly-Ala-Arg-Arg-Val-Thr-Phe+Asp-Ser-Leu-(His)6 | N | NU | Arg | Val | Thr | Phe | Asp | Ser | Leu | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Ala-Ile-Trp-Trp-Ser-Glu-Val-Val-Arg-(His)6 | Pro-Gly-Gly-Ala-Ile-Trp-Trp+Ser-Glu-Val-Val-Arg-(His)6 | N | NU | Ala | Ile | Trp | Trp | Ser | Glu | Val | Val | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Ala-Leu-Glu-Val-Tyr-Ala-Ser-Gly-Gly-(His)6 | Pro-Gly-Gly-Ala-Leu-Glu-Val-Tyr+Ala-Ser-Gly-Gly-(His)6 | N | NU | Leu | Glu | Val | Tyr | Ala | Ser | Gly | Gly | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Ala-Trp-Leu-Ala-Tyr-Thr-Asp-Ser-Val-(His)6 | Pro-Gly-Gly-Ala-Trp-Leu-Ala-Tyr+Thr-Asp-Ser-Val-(His)6 | N | NU | Trp | Leu | Ala | Tyr | Thr | Asp | Ser | Val | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Ala-Val-Ser-Phe-Ser-Phe-Thr-Thr-Leu-(His)6 | Pro-Gly-Gly-Ala-Val-Ser-Phe+Ser-Phe-Thr-Thr-Leu-(His)6 | N | NU | Ala | Val | Ser | Phe | Ser | Phe | Thr | Thr | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Ala-Val-Trp-Leu-Tyr-Ser-Glu-Arg-Leu-(His)6 | Pro-Gly-Gly-Ala-Val-Trp-Leu-Tyr+Ser-Glu-Arg-Leu-(His)6 | N | NU | Val | Trp | Leu | Tyr | Ser | Glu | Arg | Leu | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Arg-Met-Thr-Phe-Ser-Leu-Ser-Thr-Leu-(His)6 | Pro-Gly-Gly-Arg-Met-Thr-Phe+Ser-Leu-Ser-Thr-Leu-(His)6 | N | NU | Arg | Met | Thr | Phe | Ser | Leu | Ser | Thr | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Arg-Ser-Thr-Phe-Gln-Ala-Ala-Leu-Leu-(His)6 | Pro-Gly-Gly-Arg-Ser-Thr-Phe+Gln-Ala-Ala-Leu-Leu-(His)6 | N | NU | Arg | Ser | Thr | Phe | Gln | Ala | Ala | Leu | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Cys-Asp-Asn-Tyr-Glu-Asp-Ile-Arg-Arg-(His)6 | Pro-Gly-Gly-Cys-Asp-Asn-Tyr+Glu-Asp-Ile-Arg-Arg-(His)6 | N | NU | Cys | Asp | Asn | Tyr | Glu | Asp | Ile | Arg | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Gln-Ala-Tyr-Ser-Met-Ala-Leu-Pro-Tyr-(His)6 | Pro-Gly-Gly-Gln-Ala-Tyr+Ser-Met-Ala-Leu-Pro-Tyr-(His)6 | N | NU | Gly | Gln | Ala | Tyr | Ser | Met | Ala | Leu | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Gln-Val-Ala-Phe-Phe-Gly-Leu-Tyr-Asp-(His)6 | Pro-Gly-Gly-Gln-Val-Ala-Phe-Phe+Gly-Leu-Tyr-Asp-(His)6 | N | NU | Val | Ala | Phe | Phe | Gly | Leu | Tyr | Asp | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Gln-Val-Phe-Ala-Glu-Val-Arg-Leu-Gln-(His)6 | Pro-Gly-Gly-Gln-Val-Phe+Ala-Glu-Val-Arg-Leu-Gln-(His)6 | N | NU | Gly | Gln | Val | Phe | Ala | Glu | Val | Arg | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Glu-Phe-Tyr-Ser-Glu-Gly-Leu-Gly-His-(His)6 | Pro-Gly-Gly-Glu-Phe-Tyr+Ser-Glu-Gly-Leu-Gly-His-(His)6 | N | NU | Gly | Glu | Phe | Tyr | Ser | Glu | Gly | Leu | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Glu-Trp-Tyr-Glu-Ala-Ser-Gln-Gly-Gly-(His)6 | Pro-Gly-Gly-Glu-Trp+Tyr-Glu-Ala-Ser-Gln-Gly-Gly-(His)6 | N | NU | Gly | Gly | Glu | Trp | Tyr | Glu | Ala | Ser | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Gly-Ala-Leu-Leu-Tyr-Thr-Asp-Arg-Val-(His)6 | Pro-Gly-Gly-Gly-Ala-Leu-Leu-Tyr+Thr-Asp-Arg-Val-(His)6 | N | NU | Ala | Leu | Leu | Tyr | Thr | Asp | Arg | Val | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Gly-Leu-Val-Ala-Tyr-Ser-Glu-Val-Glu-(His)6 | Pro-Gly-Gly-Gly-Leu-Val-Ala-Tyr+Ser-Glu-Val-Glu-(His)6 | N | NU | Leu | Val | Ala | Tyr | Ser | Glu | Val | Glu | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Gly-Val-Arg-Tyr-Phe-Asp-Ala-Leu-Leu-(His)6 | Pro-Gly-Gly-Gly-Val-Arg-Tyr+Phe-Asp-Ala-Leu-Leu-(His)6 | N | NU | Gly | Val | Arg | Tyr | Phe | Asp | Ala | Leu | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-His-Leu-Met-Ser-Phe-Ala-Glu-Glu-Trp-(His)6 | Pro-Gly-Gly-His-Leu-Met-Ser-Phe+Ala-Glu-Glu-Trp-(His)6 | N | NU | Leu | Met | Ser | Phe | Ala | Glu | Glu | Trp | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Ile-Ala-Val-Phe-Trp-Glu-Gly-Thr-Pro-(His)6 | Pro-Gly-Gly-Ile-Ala-Val-Phe+Trp-Glu-Gly-Thr-Pro-(His)6 | N | NU | Ile | Ala | Val | Phe | Trp | Glu | Gly | Thr | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Ile-Leu-Tyr-Val-Asp-Ser-Ser-Thr-Thr-(His)6 | Pro-Gly-Gly-Ile-Leu-Tyr+Val-Asp-Ser-Ser-Thr-Thr-(His)6 | N | NU | Gly | Ile | Leu | Tyr | Val | Asp | Ser | Ser | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Leu-Ala-Glu-Tyr-Ser-Asp-Pro-Ala-Val-(His)6 | Pro-Gly-Gly-Leu-Ala-Glu-Tyr+Ser-Asp-Pro-Ala-Val-(His)6 | N | NU | Leu | Ala | Glu | Tyr | Ser | Asp | Pro | Ala | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Leu-Ile-Ser-Ser-Tyr-Gly-Leu-Glu-Leu-(His)6 | Pro-Gly-Gly-Leu-Ile-Ser-Ser-Tyr+Gly-Leu-Glu-Leu-(His)6 | N | NU | Ile | Ser | Ser | Tyr | Gly | Leu | Glu | Leu | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Leu-Leu-Leu-Phe-Ser-Gly-Gly-Phe-Leu-(His)6 | Pro-Gly-Gly-Leu-Leu-Leu-Phe+Ser-Gly-Gly-Phe-Leu-(His)6 | N | NU | Leu | Leu | Leu | Phe | Ser | Gly | Gly | Phe | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Leu-Leu-Tyr-Ser-Asp-Val-Gly-Ile-Trp-(His)6 | Pro-Gly-Gly-Leu-Leu-Tyr+Ser-Asp-Val-Gly-Ile-Trp-(His)6 | N | NU | Gly | Leu | Leu | Tyr | Ser | Asp | Val | Gly | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Leu-Trp-Ser-Val-Tyr-Phe-Glu-Pro-Met-(His)6 | Pro-Gly-Gly-Leu-Trp-Ser-Val-Tyr+Phe-Glu-Pro-Met-(His)6 | N | NU | Trp | Ser | Val | Tyr | Phe | Glu | Pro | Met | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Leu-Val-Ser-Val-Ala-Tyr-Ser-Glu-Thr-(His)6 | Pro-Gly-Gly-Leu-Val-Ser-Val-Ala-Tyr+Ser-Glu-Thr-(His)6 | N | NU | Ser | Val | Ala | Tyr | Ser | Glu | Thr | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Leu-Val-Thr-Arg-Phe-Ser-Glu-Glu-Glu-(His)6 | Pro-Gly-Gly-Leu-Val-Thr-Arg-Phe+Ser-Glu-Glu-Glu-(His)6 | N | NU | Val | Thr | Arg | Phe | Ser | Glu | Glu | Glu | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Leu-Val-Val-Tyr-Gly-Asp-Tyr-Thr-Thr-(His)6 | Pro-Gly-Gly-Leu-Val-Val-Tyr+Gly-Asp-Tyr-Thr-Thr-(His)6 | N | NU | Leu | Val | Val | Tyr | Gly | Asp | Tyr | Thr | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Phe-Leu-Ala-Val-Glu-Ala-Phe-Met-Asp-(His)6 | Pro-Gly-Gly-Phe-Leu-Ala-Val-Glu-Ala-Phe+Met-Asp-(His)6 | N | NU | Val | Glu | Ala | Phe | Met | Asp | His | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Phe-Phe-Ile-Ser-Val-Tyr-Val-Glu-Ala-(His)6 | Pro-Gly-Gly-Phe-Phe-Ile-Ser-Val-Tyr+Val-Glu-Ala-(His)6 | N | NU | Ile | Ser | Val | Tyr | Val | Glu | Ala | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Phe-Thr-Phe-Phe-Asp-Val-Gly-Ser-Tyr-(His)6 | Pro-Gly-Gly-Phe-Thr-Phe+Phe-Asp-Val-Gly-Ser-Tyr-(His)6 | N | NU | Gly | Phe | Thr | Phe | Phe | Asp | Val | Gly | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Pro-Gly-Leu-Leu-Ala-Phe-Phe-Leu-Phe-(His)6 | Pro-Gly-Gly-Pro-Gly-Leu-Leu-Ala-Phe+Phe-Leu-Phe-(His)6 | N | NU | Leu | Leu | Ala | Phe | Phe | Leu | Phe | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Ser-Met-Val-Ser-Tyr-Ala-Asp-Val-Ser-(His)6 | Pro-Gly-Gly-Ser-Met-Val-Ser-Tyr+Ala-Asp-Val-Ser-(His)6 | N | NU | Met | Val | Ser | Tyr | Ala | Asp | Val | Ser | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Ser-Val-Leu-Leu-Phe-Glu-Asp-Gly-Leu-(His)6 | Pro-Gly-Gly-Ser-Val-Leu-Leu-Phe-Glu-Asp-Gly-Leu-(His)6 | N | NU | Val | Leu | Leu | Phe | Glu | Asp | Gly | Leu | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Trp-Arg-Leu-Cys-Pro-Phe-Met-Asp-Ala-(His)6 | Pro-Gly-Gly-Trp-Arg-Leu-Cys-Pro-Phe-Met-Asp-Ala-(His)6 | N | NU | Leu | Cys | Pro | Phe | Met | Asp | Ala | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Trp-Asn-Pro-Gln-Ala-Tyr-Gly-Leu-Thr-(His)6 | Pro-Gly-Gly-Trp-Asn-Pro-Gln-Ala-Tyr+Gly-Leu-Thr-(His)6 | N | NU | Pro | Gln | Ala | Tyr | Gly | Leu | Thr | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Trp-Asp-Ala-Tyr-Asn-Glu-Ala-Val-Glu-(His)6 | Pro-Gly-Gly-Trp-Asp-Ala-Tyr+Asn-Glu-Ala-Val-Glu-(His)6 | N | NU | Trp | Asp | Ala | Tyr | Asn | Glu | Ala | Val | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Trp-Phe-Arg-Val-Ala-Val-Tyr-Gly-Ser-(His)6 | Pro-Gly-Gly-Trp-Phe-Arg-Val-Ala-Val-Tyr+Gly-Ser-(His)6 | N | NU | Val | Ala | Val | Tyr | Gly | Ser | His | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Trp-Thr-Arg-Glu-Ala-Trp-Ala-Leu-Val-(His)6 | Pro-Gly-Gly-Trp-Thr-Arg-Glu-Ala-Trp-Ala+Leu-Val-(His)6 | N | NU | Glu | Ala | Trp | Ala | Leu | Val | His | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Tyr-Val-Gly-Ser-Ser-Val-Tyr-Phe-Gly-(His)6 | Pro-Gly-Gly-Tyr-Val-Gly-Ser-Ser-Val-Tyr+Phe-Gly-(His)6 | N | NU | Ser | Ser | Val | Tyr | Phe | Gly | His | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Val-Ala-Ser-Phe-Asp-Ser-Ala-Val-Leu-(His)6 | Pro-Gly-Gly-Val-Ala-Ser-Phe+Asp-Ser-Ala-Val-Leu-(His)6 | N | NU | Val | Ala | Ser | Phe | Asp | Ser | Ala | Val | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Val-Ala-Thr-Thr-Phe-Phe-Gly-Leu-Thr-(His)6 | Pro-Gly-Gly-Val-Ala-Thr-Thr-Phe-Phe+Gly-Leu-Thr-(His)6 | N | NU | Thr | Thr | Phe | Phe | Gly | Leu | Thr | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Val-Leu-Trp-Ser-Ala-Phe-Ala-Arg-Gly-(His)6 | Pro-Gly-Gly-Val-Leu-Trp+Ser-Ala-Phe-Ala-Arg-Gly-(His)6 | N | NU | Gly | Val | Leu | Trp | Ser | Ala | Phe | Ala | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Val-Leu-Tyr-Glu-Glu-Ser-Gly-Ser-Arg-(His)6 | Pro-Gly-Gly-Val-Leu-Tyr+Glu-Glu-Ser-Gly-Ser-Arg-(His)6 | N | NU | Gly | Val | Leu | Tyr | Glu | Glu | Ser | Gly | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Val-Phe-Asp-Arg-Val-Val-Phe-Ala-Gly-(His)6 | Pro-Gly-Gly-Val-Phe-Asp-Arg-Val-Val-Phe+Ala-Gly-(His)6 | N | NU | Arg | Val | Val | Phe | Ala | Gly | His | His | Andersson et al., 2008 | ||||
| Pro-Gly-Gly-Val-Trp-Val-Val-Glu-Met-Phe-Thr-Thr-(His)6 | Pro-Gly-Gly-Val-Trp-Val-Val-Glu-Met-Phe+Thr-Thr-(His)6 | N | NU | Val | Glu | Met | Phe | Thr | Thr | His | His | Andersson et al., 2008 | ||||
| profilin | P25816 | 1-133 | peptide-Tyr6+Val-peptide | P | Trp | Gln | Thr | Tyr | Val | Asp | Glu | His | Raymond et al., 2003 | 19531 | ||
| profilin | P25816 | 1-133 | peptide-Trp35+Ala-peptide | P | Gly | Ser | Val | Trp | Ala | Gln | Ser | Ser | Raymond et al., 2003 | 19532 | ||
| profilin-1 | P07737 | 2-140 | peptide-Trp32+Ala-peptide | P | Pro | Ser | Val | Trp | Ala | Ala | Val | Pro | Raymond et al., 2003 | 3198 | ||
| serum albumin | P02768 | 25-609 | peptide-Tyr108+Gly-peptide | P | Arg | Glu | Thr | Tyr | Gly | Glu | Met | Ala | Raymond et al., 2003 | 19277 | ||
| Substance P | P20366 | 58-68 | peptide-Phe64+Phe-Gly-Leu-Met | P | MS | Pro | Gln | Gln | Phe | Phe | Gly | Leu | Met | Schiemann et al., 2006 | ||
| Substance P | P20366 | 58-68 | peptide-Phe65+Gly-Leu-Met | P | MS | Gln | Gln | Phe | Phe | Gly | Leu | Met | - | Schiemann et al., 2006 | ||
| Suc-Ala-Ala-Pro-Phe-NHPhNO2 | Suc-Ala-Ala-Pro-Phe+NHPhNO2 | S | Ala | Ala | Pro | Phe | NAN | - | - | - | Caughey, 2004 | |||||
| Suc-Phe-Pro-Phe-NHPhNO2 | Suc-Phe-Pro-Phe+NHPhNO2 | S | Suc | Phe | Pro | Phe | NAN | - | - | - | Caughey, 2004 | |||||
| synthetic consensus peptide | peptide-Tyr6+Ser-peptide | N | Gly | Val | Ala | Tyr | Ser | Glu | Ala | Ala | Andersson et al., 2008 | |||||
| tryptophanyl bond | peptide-Trp+peptide | N | - | - | NPe | Trp | CPe | - | - | - | Caughey, 2004 | |||||
| tyrosyl bond | peptide-Tyr+peptide | N | - | - | NPe | Tyr | CPe | - | - | - | Caughey, 2004 |
